Is NEXGEL, Inc. (NXGL) a Buy, Sell, or Hold?
NASDAQ : NXGL
NEXGEL, Inc.
$0.339 USD
-$0.07 (-17.52%)
- Volume
- 381.78K
- Average Volume
- 253.41K
- Market Capitalization
- $2.87M
- P/E Ratio
- -0.85
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $2.89
- Year Low
- $0.33
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.70
Company Overview
NASDAQ
Adam R. Levy
Medical - Instruments & Supplies
Healthcare
NXGL
19
US
USD
Liquidity Metrics
1.07
1.70
1.02
0.06
0.00
Sales & Valuation
$11.42M
0.26
0.70
-2.02
-0.17
Profitability
-$0.38
-$3M
-28.54%
-27.40%
-70.23%
-27.72%
P/E Metrics
-0.85
-0.07
-0.07
Analyst Price Target & Rating
1/5
1 Analysts
%
Financial Health Scores
-2.00
2/9
$2.32M
$11.6M
$7.12M
-$3.02M
Key Metrics (TTM)
$7.56M
0.67
-3.38
1.70
-70.23%
-40.29%
-95.35%
-40.88%
46 days
Company Executives
| Name | Title |
|---|---|
| Ian Blackman | Chief Financial Officer |
| Adam R. Levy | Chief Executive Officer, President & Director |
| Gregory Robb | Vice President of Operations |
Poll Results
No votes yet today — be the first to share your view!
About NEXGEL, Inc. (NASDAQ:NXGL) Stock
NEXGEL, Inc. is a company that develops and produces advanced hydrogels and gels. These materials are characterized by their significant water content, aqueous polymer composition, and electron beam cross-linking technology. NEXGEL's diverse product range serves crucial applications across several sectors, including wound care management, medical diagnostic tools, transdermal drug delivery systems, and cosmetic formulations. The company was founded in 1997 and operated under the name AquaMed Technologies, Inc. until it rebranded as NEXGEL, Inc. in November 2019. Its headquarters are located in Langhorne, Pennsylvania. ...
NEXGEL to Present at Planet MicroCap Conference Las Vegas on June 16th –18th
2026-06-04 09:00:00
LANGHORNE, Pa. , June 04, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: "NXGL"), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications, today announced that Adam Levy, Chief Executive Officer, will present at the Planet MicroCap Conference on June 16 - 18, 2026, in Las Vegas, NV.
2026-05-19 09:00:00
The study concluded that NEXGEL's hydrogel patch significantly reduced laser plume generation and exposure during laser hair removal and the patch was associated with greater hair reduction and reduced pain compared to the control The study was published in Lasers in Surgery and Medicine, 2026 LANGHORNE, Pa., May 19, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications, today announced positive data from the randomized, 30-patient, single-center Institutional Review Board (IRB) clinical study, funded by Innovative Optics, a leading supplier of safety products and personal protective equipment for medical, surgical and aesthetic healthcare facilities globally.
NEXGEL, Inc. (NXGL) Q1 2026 Earnings Call Transcript
2026-05-15 14:10:45
NEXGEL, Inc. (NXGL) Q1 2026 Earnings Call Transcript
NEXGEL Appoints Dave Hazard as Vice President of Sales for BIONX Surgical
2026-05-13 08:30:00
Appointment Supports Commercialization of Newly Launched BIONX Surgical Division, Formed Through Transformative Acquisition Expected to Significantly Scale Revenue LANGHORNE, Pa., May 13, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced the appointment of Dave Hazard as Vice President of Sales for BIONX Surgical, a division of NEXGEL.
NEXGEL To Report First Quarter 2026 Financial Results on May 15th
2026-05-12 10:27:00
Management Will Host a Conference Call at 12:00 P. M. ET on the Same Day LANGHORNE, Pa. , May 12, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: "NXGL"), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced it will report its financial results for the first quarter 2026 ended March 31, 2026, on Friday, May 15, 2026.
NEXGEL To Report First Quarter 2026 Financial Results on May 15th
2026-05-12 10:27:00
Management Will Host a Conference Call at 12:00 P.M. ET on the Same Day LANGHORNE, Pa.
Frequently Asked Questions
-
What is the current NEXGEL, Inc. (NXGL) stock price?
-
NEXGEL, Inc.(NASDAQ:NXGL) stock price is $0.339 in the last trading session. During the trading session, NXGL stock reached the peak price of $2.89 while $0.3303 was the lowest point it dropped to. The percentage change in NXGL stock occurred in the recent session was --17.52% while the dollar amount for the price change in NXGL stock was -$0.07.
-
NXGL's industry and sector of operation?
-
The NASDAQ listed NXGL is part of Medical - Instruments & Supplies industry that operates in the broader Healthcare sector.
-
Who are the executives of NXGL?
-
Ian Blackman | Chief Financial Officer
Adam R. Levy | Chief Executive Officer, President & Director
Gregory Robb | Vice President of Operations
|
| -
How many employees does NXGL have?
-
Number of NXGL employees currently stands at 19. NXGL operates from 2150 Cabot Boulevard West, Langhorne, PA 19047, US.
-
Link for NXGL official website?
-
Official Website of NXGL is: https://nexgel.com
-
How do I contact NXGL?
-
NXGL could be contacted at phone #215 702 8550 and can also be accessed through its website. NXGL operates from 2150 Cabot Boulevard West, Langhorne, PA 19047, US.
-
How many shares of NXGL are traded daily?
-
The average number of NXGL shares traded daily for last 3 months was 253.41K.
-
What is the market cap of NXGL currently?
-
The market value of NXGL currently stands at $2.87M with its latest stock price at $0.339